Question 1

What is the share price of Indo Us Bio-Tech Ltd today?

Accepted Answer

Indo Us Bio-Tech Ltd (INDOUS) is trading at ₹60.31. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is INDOUS’s P/E ratio versus the sector?

Accepted Answer

INDOUS trades at a P/E of 13.6. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is INDOUS’s dividend yield?

Accepted Answer

INDOUS has a dividend yield of 0.32%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is INDOUS’s 52-week high and low?

Accepted Answer

INDOUS has traded between ₹57.5 and ₹159 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Indo Us Bio-Tech Ltd?

Accepted Answer

Indo Us Bio-Tech Ltd has a market capitalisation of ₹156 crore.

Question 6

What is INDOUS’s return on equity?

Accepted Answer

INDOUS reports a return on equity of 15.3%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Agricultural Inputs.

Question 7

Who are INDOUS’s competitors?

Accepted Answer

The Peers block on this page lists other Agricultural Inputs companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is INDOUS’s promoter holding?

Accepted Answer

Promoters hold 68.29% of INDOUS. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include INDOUS?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight INDOUS carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Indo Us Bio-Tech Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from INDOUS’s own numbers. The judgement is yours.

Revenue	₹110 crore
Net profit	₹13 crore
Operating margin	15%
EPS	₹6.54

INDOUS

INDOUS

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

INDOUS financial summary